Quarterly report pursuant to Section 13 or 15(d)

OTHER INCOME - NET (Narrative) (Details)

v3.10.0.1
OTHER INCOME - NET (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 31, 2018
Aug. 31, 2018
Aug. 31, 2017
Net gain on remeasurement of previously equity interest in Atvio and CureCell to acquisition date fair value $ 4,509 $ 4,509 $ 0
Transaction expenses related to GPP agreement $ 1,500 $ 1,500